drugset
drugset / Trial / NCT02402595

Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts

NCT02402595 ↗

Phase 1 Completed 24 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.
RandomizedCrossoverTriple-blindOther

Summary

The purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.

Timeline

Start
2015-03-01
Primary completion
2015-07-01
Completion
2015-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AVP-786 Unknown — —
Subject AVP-923 Unknown — —
Subject Itraconazole Small molecule 200 mg —

Indications

No indication recorded.